Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Genome-wide binding map of the HIV-1 Tat protein to the human genome.

Marban C, Su T, Ferrari R, Li B, Vatakis D, Pellegrini M, Zack JA, Rohr O, Kurdistani SK.

PLoS One. 2011;6(11):e26894. doi: 10.1371/journal.pone.0026894. Epub 2011 Nov 4.

2.

Acetylation of HIV-1 Tat by CBP/P300 increases transcription of integrated HIV-1 genome and enhances binding to core histones.

Deng L, de la Fuente C, Fu P, Wang L, Donnelly R, Wade JD, Lambert P, Li H, Lee CG, Kashanchi F.

Virology. 2000 Nov 25;277(2):278-95.

3.

Effect of SWI/SNF chromatin remodeling complex on HIV-1 Tat activated transcription.

Agbottah E, Deng L, Dannenberg LO, Pumfery A, Kashanchi F.

Retrovirology. 2006 Aug 7;3:48.

4.

Enhancement of nuclear factor-kappa B acetylation by coactivator p300 and HIV-1 Tat proteins.

Furia B, Deng L, Wu K, Baylor S, Kehn K, Li H, Donnelly R, Coleman T, Kashanchi F.

J Biol Chem. 2002 Feb 15;277(7):4973-80. Epub 2001 Dec 5.

5.

The histone chaperone protein Nucleosome Assembly Protein-1 (hNAP-1) binds HIV-1 Tat and promotes viral transcription.

Vardabasso C, Manganaro L, Lusic M, Marcello A, Giacca M.

Retrovirology. 2008 Jan 28;5:8. doi: 10.1186/1742-4690-5-8.

7.

Cooperative interaction between HIV-1 regulatory proteins Tat and Vpr modulates transcription of the viral genome.

Sawaya BE, Khalili K, Gordon J, Taube R, Amini S.

J Biol Chem. 2000 Nov 10;275(45):35209-14.

8.

Enhancement of the p300 HAT activity by HIV-1 Tat on chromatin DNA.

Deng L, Wang D, de la Fuente C, Wang L, Li H, Lee CG, Donnelly R, Wade JD, Lambert P, Kashanchi F.

Virology. 2001 Oct 25;289(2):312-26.

10.

Chromatin control of HIV-1 gene expression.

Marzio G, Giacca M.

Genetica. 1999;106(1-2):125-30. Review.

PMID:
10710718
11.
13.

Human immunodeficiency virus type-1 Tat/co-activator acetyltransferase interactions inhibit p53Lys-320 acetylation and p53-responsive transcription.

Harrod R, Nacsa J, Van Lint C, Hansen J, Karpova T, McNally J, Franchini G.

J Biol Chem. 2003 Apr 4;278(14):12310-8. Epub 2002 Dec 24.

15.

Association of HIV-1 Tat with the cellular protein, Puralpha, is mediated by RNA.

Gallia GL, Darbinian N, Tretiakova A, Ansari SA, Rappaport J, Brady J, Wortman MJ, Johnson EM, Khalili K.

Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11572-7.

16.

Human immunodeficiency virus 1 Tat binds to dipeptidyl aminopeptidase IV (CD26): a possible mechanism for Tat's immunosuppressive activity.

Gutheil WG, Subramanyam M, Flentke GR, Sanford DG, Munoz E, Huber BT, Bachovchin WW.

Proc Natl Acad Sci U S A. 1994 Jul 5;91(14):6594-8.

17.
18.

Activation of integrated provirus requires histone acetyltransferase. p300 and P/CAF are coactivators for HIV-1 Tat.

Benkirane M, Chun RF, Xiao H, Ogryzko VV, Howard BH, Nakatani Y, Jeang KT.

J Biol Chem. 1998 Sep 18;273(38):24898-905.

19.

Nuclear Factor 90(NF90) targeted to TAR RNA inhibits transcriptional activation of HIV-1.

Agbottah ET, Traviss C, McArdle J, Karki S, St Laurent GC 3rd, Kumar A.

Retrovirology. 2007 Jun 12;4:41.

20.

Interaction of YB-1 with human immunodeficiency virus type 1 Tat and TAR RNA modulates viral promoter activity.

Ansari SA, Safak M, Gallia GL, Sawaya BE, Amini S, Khalili K.

J Gen Virol. 1999 Oct;80 ( Pt 10):2629-38.

PMID:
10573156

Supplemental Content

Support Center